Internet Explorer Alert

It appears you are using Internet Explorer as your web browser. Please note, Internet Explorer is no longer up-to-date and can cause problems in how this website functions
This site functions best using the latest versions of any of the following browsers: Edge, Firefox, Chrome, Opera, or Safari.
You can find the latest versions of these browsers at https://browsehappy.com

EQIPP: Antibiotic Decision Making

MOC

Available: 09/22/2021-09/21/2025

Format

Price: $199.00
Member Price: $0.00

Description

This course is eligible for a total of 100 ABP MOC 4 points.
Points can be claimed based on the number of tracks completed (25 MOC 4 points per completed track).

  

This course is designed to help guide clinicians on the judicious use of antibiotics based on accurate diagnosis and effective treatment of common pediatric infections. It provides information on how to educate families about appropriate antibiotic prescribing.

If recommendations for proper diagnosis and treatment of common pediatric conditions are followed, the quality of care for the child will improve and unnecessary antibiotic exposure, cost, and the emergence of antibiotic resistance will be reduced.

This course includes four tracks for data collection related to common infections seen in pediatric patients: viral upper respiratory infection, acute otitis media, Group A streptococcal pharyngitis, and acute bacterial sinusitis.


Course Goals:

The goals of this EQIPP course include:

  • Become familiar with current guidelines and recommendations for the diagnosis and treatment of common pediatric infections, including upper respiratory infection (URI), acute otitis media, group A streptococcal pharyngitis and acute bacterial sinusitis.
  • Practice and promote antibiotic stewardship by prescribing antibiotics only when necessary and promoting the use of appropriate agent(s), dose, duration, and route of therapy to optimize clinical outcomes while minimizing the unintended consequences of antibiotic use.
  • Identify areas of improvement needed in practice related to the diagnosis, treatment, and guidance offered to families regarding common pediatric infections and judicious antibiotic prescribing. Recognize barriers that may impede changes, identify processes/resources to overcome these barriers, and create plans for improvement. (You will collect baseline and follow-up data as you work to improve care and processes through Plan, Do, Study, and Act [PDSA] cycles.)

Learning Objectives:

By the end of this course, you will able to:

  • Accurately diagnose and treat common pediatric infections, including upper respiratory infection (URI), acute otitis media, group A streptococcal pharyngitis, and acute bacterial sinusitis to ensure appropriate and effective treatment.
  • Differentiate between viral and bacterial infections.
  • Treat patients effectively, using antibiotics only when indicated and prescribed appropriately.
    • Avoid misuse of antibiotics by not treating patients when antibiotics have no benefit.
    • Prescribe narrow-spectrum antibiotics vs broad-spectrum antibiotics when viable to limit antibiotic resistance and unnecessary healthcare costs, while maintaining high-quality care.
    • Identify dangers of inappropriate use of antibiotics.
  • Develop a practice policy concerning judicious use and prescribing of antibiotics and communicate it to patients and and families.
    • Provide information to patients and families about the benefits and risks of antibiotic use.
    • Provide guidance and education to patients and families about the benefits of judicious use of antibiotics for mitigating antibiotic resistance and adverse events for patients.
    • Respond effectively to patients and families when unnecessary antibiotics are requested.
  • Assess the diagnostic and prescribing patterns of your practice.

Course Details

  • Start Date: September 22, 2021
  • Online Access Expires: September 21, 2025
  • Credit Expires: September 21, 2025
  • Activity Type: Asynchronous Online Course
  • Course ID: 59465

Acknowledgements

No commercial support.

Faculty

Angela L. Myers MD, MPH

Ritu Banerjee, MD, PhD, FAAP

Jeffrey Stephen Gerber, MD PhD

AAP Member: Included with membership

AAP Resident Member: Included with membership

AAP Fellow in Training Member: Included with membership

Non-Member: $199

  • AMA PRA Category 1 Credit™

  • Enduring Materials

    9.00
  • PI CME

    80.00
  • AAP Credit Only

  • AAP Credit

    89.00
  • NAPNAP

  • NAPNAP Credit Contact Hours

    89.00
  • NAPNAP Pharmacology Rx

    2.75
  • MOC

  • MOC Part 2

    9.00
  • MOC Part 4

    100.00

Physician - EQIPP: Antibiotic Decision Making

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAP designates this enduring material for a maximum of 9.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAP designates this PI CME activity for a maximum of 80.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is acceptable for a maximum of 89.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.

This activity is approved for 9.00 points of MOC Part 2 credit by the American Board of Pediatrics through the AAP MOC Portfolio Program.  All approved activities must be completed by the MOC Credit Approval End Date. All deadlines and MOC point values should be confirmed by checking the ABP Activity Catalog within each physician’s ABP Portfolio. Consult your ABP portfolio at www.abp.org for details about your specific certification requirements. For questions about how to access this activity, contact [email protected].

This activity is approved for 100.00 MOC Part 4 points by the American Board of Pediatrics through the AAP MOC Portfolio Program. All points will be awarded (or must be claimed) based on the MOC activity completion date, which is the date MOC requirements were met. All deadlines and MOC point values should be confirmed by checking the ABP Activity Catalog within each physician's ABP Portfolio. Consult your ABP portfolio at www.abp.org for details about your specific certification requirements. For questions about how to access this activity, contact [email protected].


Allied Health Professional - EQIPP: Antibiotic Decision Making

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This program is accredited for 89.00 NAPNAP CE contact hours of which 2.75 contain pharmacology (Rx) content, (0.00 related to psychopharmacology) (0.00 related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines. The AAP is designated as Agency #A17. Upon completion of the program, each participant desiring NAPNAP contact hours must send a completed certificate of attendance to [email protected]. Payment of $15 for NAPNAP members and nonmembers is required via credit card for all NAPNAP contact hour requests. Keep this certificate for your records for six (6) years. Requests for duplicate certificates should be made to the AAP.

Recommended Browsers:

  • Microsoft Edge
  • Google Chrome
  • Firefox 2.0 and above
  • Opera 7.5 and above
  • Safari 1.3.2 and above

Recommended Browser Settings:

  • JavaScript enabled
  • Cookie enabled
  • SSL 2.0 & 3.0 enabled
  • Adobe Reader Plug-in (version 6.0+)

EQIPP: Antibiotic Decision Making

Price:: 199.00

Feedback Form